12:00 AM
 | 
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Fabrazyme agalsidase beta: Post-marketing study started

Genzyme began the 5-year, international post-marketing FIELD trial to evaluate 0.5 mg/kg Fabrazyme given every 2 weeks or 1 mg/kg Fabrazyme...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >